|
|
Volumn 57, Issue 8, 2006, Pages 1075-
|
|
What the CATIE study means for clinical practice
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG USE;
EDITORIAL;
HUMAN;
MEDICAL DECISION MAKING;
MENTAL PATIENT;
PSYCHOSIS;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 33746948360
PISSN: 10752730
EISSN: None
Source Type: Journal
DOI: 10.1176/ps.2006.57.8.1075 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
